Financial Enhancement Group LLC grew its position in Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Rating) by 25.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,401 shares of the company's stock after purchasing an additional 882 shares during the period. Financial Enhancement Group LLC owned about 0.10% of Innovator IBD 50 ETF worth $172,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of FFTY. Rockbridge Investment Management LCC acquired a new position in Innovator IBD 50 ETF in the 4th quarter worth about $54,000. Wealthcare Advisory Partners LLC increased its position in Innovator IBD 50 ETF by 9.5% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 5,413 shares of the company's stock worth $212,000 after purchasing an additional 468 shares during the last quarter. Kestra Advisory Services LLC acquired a new position in Innovator IBD 50 ETF in the 1st quarter worth about $230,000. IHT Wealth Management LLC increased its holdings in shares of Innovator IBD 50 ETF by 6.5% during the 1st quarter. IHT Wealth Management LLC now owns 11,193 shares of the company's stock valued at $438,000 after acquiring an additional 685 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new position in shares of Innovator IBD 50 ETF during the 1st quarter valued at about $481,000.
Get Innovator IBD 50 ETF alerts:Innovator IBD 50 ETF Price Performance
Shares of NYSEARCA FFTY opened at $27.68 on Wednesday. The business's 50-day simple moving average is $28.24 and its 200-day simple moving average is $31.73. Innovator IBD 50 ETF has a 52 week low of $26.13 and a 52 week high of $52.55.
Further Reading
- Get a free copy of the StockNews.com research report on Innovator IBD 50 ETF (FFTY)
- These 3 Reports Will Tell Us Much About the Current Economy
- Is Five Below Trying to Punch Too High?
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
